{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-409052","form_type":"8-K","ticker":"BNTC","cik":"0001808898","company_name":"Benitec Biopharma Inc.","filed_at":"2026-09-30T20:08:28+00:00","discovered_at":"2026-09-30T20:09:00.429912+00:00","generated_at":"2026-10-12T14:04:52.890174+00:00","sec_items":["4.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"Benitec engages Ernst & Young as auditor for fiscal year ending June 30, 2027","bullets":["EY completed its client acceptance process on September 28, 2026, and executed the engagement letter with Benitec on September 29, 2026.","The EY engagement covers the fiscal year ending June 30, 2027; the approval was previously disclosed in a Form 8-K filed September 24, 2026.","Filing is an Item 4.01 change-in-certifying-accountant notice; no resignation, disagreement, or restatement disclosure is provided.","Signed by Chief Executive Officer Dr. Jerel A. Banks, dated September 30, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-409052","json":"https://secwatch.observer/filing/0001193125-26-409052.json","markdown":"https://secwatch.observer/filing/0001193125-26-409052.md","text":"https://secwatch.observer/filing/0001193125-26-409052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526409052/0001193125-26-409052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526409052/bntc-20260929.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:04:52.890174+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}